Last reviewed · How we verify
NCT03599583: STOP-HPV
The STOP-HPV Trial 3: Prompts Intervention
NA trial testing STOP-HPV prompts intervention in Immunization in 48 participants. Status unknown.
15 July 2022
Quick facts
| Lead sponsor | University of California, Los Angeles |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 48 |
| Start date | 7 August 2018 |
| Primary completion | 15 July 2022 |
| Estimated completion | 15 July 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- STOP-HPV prompts intervention
Conditions studied
- Immunization — all drugs for Immunization →
- Vaccination — all drugs for Vaccination →
Sponsor
University of California, Los Angeles
Who can join
Adults 11 to 17, any sex, with Immunization or Vaccination. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Most adolescents who receive human papillomavirus (HPV) vaccine are vaccinated in pediatric practices, yet missed opportunities (MOs) for HPV vaccination occur often and lead to low HPV vaccination rates. This study is part of a series of cluster randomized clinical trials (RCTs) that will test the effectiveness (and cost-effectiveness) of the addition of prompts (period 3) to performance feedback (period 2, continued through period 3) and training providers previously received on HPV vaccine communication (period 1) to reduce MOs and increase HPV vaccination rates.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinician Prompts for Human Papillomavirus Vaccination: A Cluster Randomized Trial.
Rand CM, Stephens-Shields AJ, Kelly MK, Localio R, et al · · 2024 · cited 3× · PMID 37925070 · DOI 10.1016/j.acap.2023.10.011
Verify or expand the search:
- PubMed search for NCT03599583
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Immunization
Currently open trials in the same condition.
- NCT06718127 — Description of the Immune Response to Yellow Fever Vaccination · NA · recruiting
- NCT05213000 — Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress · NA · recruiting
Other University of California, Los Angeles trials
Trials by the same sponsor.
- NCT04846517 — rTMS for Aneroxia Nervosa in Youth · NA · not yet recruiting
- NCT06701760 — Sodium Lactate in Severe TBI · Phase 2 · not yet recruiting
- NCT04996667 — Effect of iNO in Patients With Submassive and Massive PE · Phase 2 · withdrawn
- NCT05067387 — Evaluation of Oral THC and CBD in Men and Women · Phase 1 · not yet recruiting
- NCT07534696 — Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03599583 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, Los Angeles
- Last refreshed: 12 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03599583.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing